BELLICUM PHARMACEUTICALS

Bellicum Pharmaceuticals is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.
BELLICUM PHARMACEUTICALS
Industry:
Biotechnology Health Care Health Diagnostics Oncology Therapeutics
Founded:
2004-07-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.bellicum.com
Total Employee:
11+
Status:
Active
Contact:
(832) 384-1100
Total Funding:
324.58 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Pound Sterling Common Name Invalid Microsoft Japanese Yen COVID-19 Sectigo SSL Sectigo Domain SSL Unified Layer
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aer Therapeutics
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Advisor
Advisor
Advisor
Board_member
Board_member
Advisor
Current Employees Featured
Kevin Slawin Founder @ Bellicum Pharmaceuticals
Founder
2004-01-01
Aaron Foster Vice President of Product Discovery @ Bellicum Pharmaceuticals
Vice President of Product Discovery
2016-06-01
Joseph Senesac Senior Vice President & Technical Operations @ Bellicum Pharmaceuticals
Senior Vice President & Technical Operations
2021-03-01
Kevin Slawin Founder @ Bellicum Pharmaceuticals
Founder
2004-01-01
Gregory Naeve Chief Business Officer @ Bellicum Pharmaceuticals
Chief Business Officer
2017-09-01
Jaa Roberson Vice President, Human Resources @ Bellicum Pharmaceuticals
Vice President, Human Resources
2018-01-01
Daniel Von Hoff Clinical Advisory Board @ Bellicum Pharmaceuticals
Clinical Advisory Board
William Grossman SVP, Chief Medical Officer @ Bellicum Pharmaceuticals
SVP, Chief Medical Officer
2018-01-01
Rick Fair President & CEO @ Bellicum Pharmaceuticals
President & CEO
2017-01-01
Annemarie Moseley Consultant @ Bellicum Pharmaceuticals
Consultant
2017-08-01
Founder
Stock Details
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Bellicum Pharmaceuticals
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Bellicum Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series C - Bellicum Pharmaceuticals
Ridgeback Capital
Ridgeback Capital investment in Series C - Bellicum Pharmaceuticals
Ridgeway Capital Partners
Ridgeway Capital Partners investment in Series C - Bellicum Pharmaceuticals
Sabby Capital
Sabby Capital investment in Series C - Bellicum Pharmaceuticals
Aju IB Investment
Aju IB Investment investment in Series C - Bellicum Pharmaceuticals
Jennison Associates
Jennison Associates investment in Series C - Bellicum Pharmaceuticals
Redmile Group
Redmile Group investment in Series C - Bellicum Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series C - Bellicum Pharmaceuticals
Official Site Inspections
http://www.bellicum.com Semrush global rank: 3.9 M Semrush visits lastest month: 2.91 K
- Host name: 192-185-225-144.unifiedlayer.com
- IP address: 192.185.225.144
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092

More informations about "Bellicum Pharmaceuticals"
Bellicum Pharmaceuticals
Feb 25, 2025 Bellicum was founded in 2004. The company has raised over $300 million in venture capital and public markets to date as it develops its pipeline of novel cellular …See details»
BeLocum | Pharmacy & Dental Staffing Solutions in Canada
Belocum provides top-tier pharmacy and dental staffing solutions across Canada. Discover the perfect match for your staffing needs with BelocumSee details»
Investor Center Home - Bellicum
Jan 31, 2023 Bellicum is a biopharmaceutical company that has engineered the newest wave of high-performance cellular technology, unleashing the power of potentially curative IO …See details»
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. (E xac t n ame of re gi s tr an t as s p e c i fi e d i n i ts c h ar te r ) D e l aw are. 20-1450200 (S tate or oth e r ju r i s d i c ti on of i n c or p or ati on or or gan i z …See details»
Bellicum Pharmaceuticals Company Profile & Introduction
Introduction of Bellicum Pharmaceuticals, including company profile, stock information, contact number, and company business introduction.See details»
bellicum.com - Whois.com
Whois Lookup for bellicum.com. Domain Services Transfer your Domain Consolidate your domains quickly & easily Free With Every Domain Free services included with every domainSee details»
Search - Bellicum
The Investor Relations website contains information about Bellicum's business for stockholders, potential investors, and financial analysts.See details»
[2022] Bellicum Pharmaceuticals Inc Organizational Resilience …
Organization Resilience Introduction . The world is going through two major crises at the moment – Covid 19 health crisis and the on-going US China trade war that can determine the future of …See details»
Bellicum Pharmaceuticals Enters into Research Collaboration with …
Jun 2, 2016 New collaboration builds on current license and research agreement for TCR candidates, including BPX-701. HOUSTON--(BUSINESS WIRE)--Jun. 2, 2016-- Bellicum …See details»
Organization | Bellicum Pharmaceuticals
Bellicum Pharmaceuticals Report issue. For profit Phase 1 Phase 2 Phase 3. Founded: Houston TX United States (2004 ... Organization Overview. First Clinical Trial. 2009 NCT00868595. …See details»
Bellicum Pharmaceuticals Company Profile -Sales, Contacts, …
Bellicum Pharmaceuticals, Inc. (trade name BELLICUM) is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number. Enter company …See details»
Bellicum - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 11, 2025 Bellicum has raised a total funding of $138M over 11 rounds. Its first funding round was on Oct 09, 2007. Its latest funding round was a Series C round on Sep 02, 2014 for …See details»
Bellicum Pharmaceuticals, Inc. (Bellicum Pharmaceuticals, Inc.) - 药 …
May 7, 2025 了解Bellicum Pharmaceuticals, Inc. (Bellicum Pharmaceuticals, Inc.)公司的药物管线,治疗领域,技术平台,以及它的28项临床试验, 70篇新闻和88篇文献,疾病领域:肿瘤,免 …See details»
Bellicum Reports First Quarter 2021 Financial Results and Provides ...
May 17, 2021 Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update 05/17/21 at 7:30 AM EDT HOUSTON, May 17, 2021 (GLOBE NEWSWIRE) -- …See details»
Bellicum Pharmaceuticals Inc | AP News - Associated Press News
Mideast Wars Israel-Hamas War Russia-Ukraine War Global elections ESPAÑOL China Asia PacificSee details»
Bellicum - Overview, News & Similar companies | ZoomInfo.com
Mar 14, 2023 Who is Bellicum. Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular …See details»
Bellicum’s Competitors, Revenue, Number of Employees, Funding …
Bellicum’s Profile, Revenue and Employees. Bellicum focuses on discovering and developing cellular immunotherapies for cancer and orphan inherited blood disorders. Bellicum’s primary …See details»
Bellicum Pharmaceuticals Company Profile & Introduction
May 21, 2025 Bellicum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological …See details»
About BELLICUM PHARMACEUTICALS, INC | DxMultiomics
Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company’s next-generation product candidates are …See details»
Bellicum Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
May 7, 2025 Explore Bellicum Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 28 clinical trials, 63 news, and 88 literature, Disease Domain:Neoplasms, …See details»